UnitedHealth Group (NYSE:UNH) Issues Quarterly Earnings Results

UnitedHealth Group (NYSE:UNH) issued its quarterly earnings data on Tuesday. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55, reports. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. During the same quarter last year, the firm earned $2.59 EPS.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $377.98 on Tuesday. The company has a market cap of $339.27 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 1.43 and a beta of 0.60. The business has a 50 day moving average price of $388.03 and a 200 day moving average price of $381.81. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 59.72%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted third-quarter earnings of $4.69 per share, ahead of the $4.12 analyst consensus and up from $2.92 a year earlier. Reported net income was $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the prior-year quarter. UnitedHealth Group Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: The company raised its full-year 2026 earnings outlook to approximately $19.50-$20.00 per share, signaling greater confidence in profitability and supporting the stock’s rally. UnitedHealth Group tops estimates and hikes profit outlook
• Positive Sentiment: Medical-cost management showed improvement, a key issue for health insurers. UnitedHealth also cited progress from value-based care and artificial-intelligence investments, suggesting potential support for longer-term margins and efficiency. UnitedHealth Earnings Beat Wall Street Estimates
• Neutral Sentiment: Optum Health revenue declined, creating a potential constraint on overall growth even as the company delivered better earnings and raised guidance. Investors are likely to watch whether improved margins can offset weaker top-line performance. UnitedHealth raises guidance as Optum Health revenue slips

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on UNH shares. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and raised their price target for the company from $287.00 to $453.00 in a report on Thursday, July 16th. Erste Group Bank downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Zacks Research lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Monday, September 14th. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a research note on Friday, July 17th. Finally, Wells Fargo & Company upped their target price on UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $462.59.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.19% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.